|
CENPF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63735691671718E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.59629999999067E-06 |
| Normal-vs-Stage2 |
4.879800E-02 |
| Normal-vs-Stage3 |
1.94288999999515E-05 |
| Normal-vs-Stage4 |
2.304000E-02 |
| Stage1-vs-Stage2 |
4.187200E-01 |
| Stage1-vs-Stage3 |
5.372200E-04 |
| Stage1-vs-Stage4 |
5.413500E-02 |
| Stage2-vs-Stage3 |
1.661790E-02 |
| Stage2-vs-Stage4 |
8.921900E-02 |
| Stage3-vs-Stage4 |
5.568600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06879949335337E-10 |
| Normal-vs-AfricanAmerican |
2.410200E-04 |
| Normal-vs-Asian |
4.909600E-02 |
| Caucasian-vs-AfricanAmerican |
2.421000E-01 |
| Caucasian-vs-Asian |
8.810600E-01 |
| AfricanAmerican-vs-Asian |
5.025200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.76970019036571E-10 |
| Normal-vs-Female |
9.65410000053346E-07 |
| Male-vs-Female |
1.301870E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.599900E-04 |
| Normal-vs-Extreme_Weight |
3.78109999976672E-07 |
| Normal-vs-Obese |
3.4681999999675E-06 |
| Normal-vs-Extreme_Obese |
2.664200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.657700E-02 |
| Normal_Weight-vs-Obese |
8.981200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.941600E-03 |
| Extreme_Weight-vs-Obese |
1.359520E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.707900E-02 |
| Obese-vs-Extreme_Obese |
3.952800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.842300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.9121999539351E-09 |
| Normal-vs-Age(61-80Yrs) |
2.33589999999451E-05 |
| Normal-vs-Age(81-100Yrs) |
2.031700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.943700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.090400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.759700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.533800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.140210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.464600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.19459999994953E-06 |
| Normal-VS-Type2 PRCC |
1.91970999999791E-05 |
| Normal-VS-KIRP CIMP |
6.574800E-04 |
| Normal-VS-Unclassified PRCC |
1.982130E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.909760E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.436690E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.819900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.19010000002129E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
5.447200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.601800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.014700E-04 |
| Normal-vs-N1 |
4.03890000000295E-05 |
| Normal-vs-N2 |
9.503800E-02 |
| N0-vs-N1 |
7.444200E-04 |
| N0-vs-N2 |
1.328290E-02 |
| N1-vs-N2 |
6.384800E-01 |
|
|
